Harbor Capital Advisors Inc. Has $3.44 Million Stock Position in HealthEquity, Inc. (NASDAQ:HQY)

Harbor Capital Advisors Inc. raised its stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 86,411.1% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 38,930 shares of the company's stock after buying an additional 38,885 shares during the period. Harbor Capital Advisors Inc.'s holdings in HealthEquity were worth $3,440,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Wealthfront Advisers LLC bought a new stake in HealthEquity during the fourth quarter worth approximately $10,304,089,000. Vanguard Group Inc. boosted its stake in shares of HealthEquity by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 8,976,091 shares of the company's stock worth $861,256,000 after acquiring an additional 99,624 shares in the last quarter. FMR LLC grew its holdings in shares of HealthEquity by 2.4% in the 4th quarter. FMR LLC now owns 5,415,800 shares of the company's stock worth $519,646,000 after acquiring an additional 125,684 shares during the last quarter. Geode Capital Management LLC raised its position in shares of HealthEquity by 0.5% during the fourth quarter. Geode Capital Management LLC now owns 2,089,398 shares of the company's stock worth $200,522,000 after purchasing an additional 10,421 shares during the period. Finally, Brown Advisory Inc. lifted its holdings in shares of HealthEquity by 12.0% during the fourth quarter. Brown Advisory Inc. now owns 2,086,026 shares of the company's stock valued at $200,154,000 after purchasing an additional 224,016 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research analysts have commented on the stock. Wall Street Zen upgraded shares of HealthEquity from a "hold" rating to a "buy" rating in a report on Friday, June 6th. KeyCorp cut their target price on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 16th. Wells Fargo & Company raised their target price on HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 26th. Deutsche Bank Aktiengesellschaft upped their price target on HealthEquity from $98.00 to $115.00 and gave the company a "buy" rating in a research report on Thursday, June 5th. Finally, Royal Bank of Canada increased their price target on shares of HealthEquity from $112.00 to $117.00 and gave the stock an "outperform" rating in a research report on Wednesday, June 4th. One research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Buy" and a consensus target price of $118.09.

Insider Activity at HealthEquity

In other news, EVP Elimelech Rosner sold 58,000 shares of the stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $112.56, for a total value of $6,528,480.00. Following the completion of the sale, the executive vice president now directly owns 75,689 shares of the company's stock, valued at approximately $8,519,553.84. This represents a 43.38% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Jon Kessler sold 134,183 shares of the stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $112.08, for a total transaction of $15,039,230.64. Following the completion of the sale, the director now owns 253,510 shares of the company's stock, valued at approximately $28,413,400.80. The trade was a 34.61% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 304,581 shares of company stock worth $33,664,018. 1.50% of the stock is owned by insiders.

HealthEquity Stock Down 1.0%

HealthEquity stock traded down $1.06 during mid-day trading on Thursday, hitting $103.50. 227,624 shares of the company's stock were exchanged, compared to its average volume of 832,806. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $116.65. The stock has a 50 day moving average of $92.93 and a two-hundred day moving average of $97.88. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The stock has a market cap of $8.95 billion, a P/E ratio of 94.95, a P/E/G ratio of 1.60 and a beta of 0.49.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings data on Tuesday, June 3rd. The company reported $0.97 EPS for the quarter, beating analysts' consensus estimates of $0.81 by $0.16. HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. The business had revenue of $330.80 million for the quarter, compared to analyst estimates of $322.25 million. During the same quarter in the prior year, the firm posted $0.80 EPS. As a group, analysts anticipate that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.